OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has been named a Gold Winner in the 2025 Merit Awards for Business in the Research and Development category.
Mark Fish, VP and GM of Digital Lab Solutions discusses the importance of making automation more accessible for labs across industries with the next generation of innovation.
IMCD Group, a specialist in the distribution and formulation of speciality chemicals and ingredients, announces the official opening of its newly reorganised and expanded Life Science Laboratory hub in Shanghai.
Upperton Pharma Solutions is the winner of the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.
Teknomek has added the Hupfer Easy Rider shelving system to its product portfolio, designed to solve one of the biggest challenges for organisations working in the pharmaceutical or healthcare sectors: lack of storage space.
Almac Clinical Services, part of the Almac Group, has completed a multi-million-pound investment to enhance cold chain capabilities at its global headquarters in Craigavon, Northern Ireland.
The biotech company, Pila Pharma, is raising 20 million Swedish kronor in an almost fully covered capital raise, which includes a stock option for future use.
Ellen Varelas, founder & CEO of LectureLinx, a global provider of innovative compliance technology and services solutions for the bio-pharmaceutical industry discusses the importance of compliance in the pharma industry.
Mettler-Toledo Product Inspection will be exhibiting at PPMA Total Show 2025 from 23rd–25th September at the NEC Birmingham, showcasing a range of contamination detection and compliance technologies.
HORIBA, a specialist in analytical and measurement technology, has expanded its worldwide network of Analytical Solution Plazas with the opening in the UK of its latest advanced technology centre.
Biocon Biologics, a fully integrated global biosimilars company and subsidiary of Biocon, has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisations in the UK for Vevzuo and Evfraxy.
